EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Potentiation of 5-hydroxytryptamine-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine



Potentiation of 5-hydroxytryptamine-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine



European Journal of Pharmacology 217(2-3): 109-118



This study examined the effects of chlorpheniramine, citalopram and fluoxetine on 5-hydroxytryptamine (5-HT)-induced contraction and 5-HT uptake in rat thoracic aortic rings in vitro. Chlorpheniramine and citalopram markedly potentiated 5-HT-induced contraction. Potentiation by fluoxetine was less pronounced. Chlorpheniramine (0.01-1 microM) and citalopram (0.1-1 microM) induced concentration-dependent parallel shifts to the left of the 5-HT concentration-response curves. The potentiation by chlorpheniramine was selective as chlorpheniramine (1 microM) did not potentiate phenylephrine-induced contraction. The potentiation did not depend upon the presence of endothelium, and was not related to H1 receptor antagonism as diphenhydramine and pyrilamine (1 microM) did not similarly enhance 5-HT-induced contractions. Whereas cocaine (1-10 microM) similarly potentiated 5-HT-induced contraction, imipramine (1-10 microM) inhibited, rather than enhanced, contraction elicited by 5-HT. In the presence of 10 microM cocaine, maximally effective concentrations of chlorpheniramine (1 microM) or citalopram (100 nM) did not induce any additional potentiation of 5-HT-induced contraction. Cooling (4 degrees C) markedly inhibited uptake of [3H]5-HT in rings with and without endothelium. Although less marked, imipramine (10 microM), cocaine (1 microM), chlorpheniramine (1 microM) and citalopram (100 nM) inhibited [3H]5-HT uptake in endothelium-intact and endothelium-denuded rings. Fluoxetine also inhibited [3H]5-HT uptake, but the inhibition was only statistically significant in endothelium-intact rings. The monoamine oxidase (MAO) inhibitor, pargyline (10-100 microM), did not significantly affect 5-HT-induced contraction. The results demonstrate that chlorpheniramine, citalopram and to a lesser extent, fluoxetine potentiate 5-HT-induced contraction in rat aorta in which neuronal 5-HT uptake is negligible. The data are consistent with inhibition of non-neuronal 5-HT uptake as at least one mechanism responsible for potentiation of 5-HT-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine.

(PDF same-day service: $19.90)

Accession: 041026002

Download citation: RISBibTeXText

PMID: 1358631

DOI: 10.1016/0014-2999(92)90827-q



Related references

Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: Role of pharmacokinetics. Life Sciences 71(11): 1341-1347, August 2, 2002

Potentiation by melatonin of 5-hydroxytryptamine-induced contraction in pig coronary artery. Research Communications in Pharmacology & Toxicology 6(1-2): 47-57, 2001

Potentiation by endothelin-1 of 5-hydroxytryptamine-induced contraction in coronary artery of the pig. Japanese Journal of Pharmacology 58 Suppl 2: 281p-281p, 1992

5-Hydroxytryptamine-induced potentiation of endothelin-1- and norepinephrine-induced contraction is mitogen-activated protein kinase pathway dependent. Hypertension 35(1 Pt 2): 244-248, 2000

5-Hydroxytryptamine-induced contraction of the marmoset aorta is mediated by a 5-HT1-like receptor. Clinical & Experimental Pharmacology & Physiology. 25(3-4): 246-251, Ch- Il, 1998

Inhibition of norepinephrine- and 5-hydroxytryptamine-induced contraction on rat aorta by dihydroergocristine. Il Farmaco; Edizione Scientifica 39(3): 208-216, 1984

Comparison of 5-hydroxytryptamine-induced contraction of rat pulmonary artery to that of aorta in vitro. Japanese Circulation Journal 59(2): 89-97, 1995

The cytochrome p450 inhibitor ketoconazole potentiates 5-hydroxytryptamine-induced contraction in rat aorta. Journal of Pharmacology and Experimental Therapeutics 323(2): 606-613, 2007

The alpha 1-adrenoceptor agonist, SDZ NVI-085, behaves as a potent, competitive antagonist of 5-hydroxytryptamine-induced contraction of rat aorta. European Journal of Pharmacology 287(3): 309-312, 1995

The potentiation of norepinephrine-induced contraction of rabbit aorta by Mg2+ deletion in a Ca2+-free medium. Magnesium 8(3-4): 137-144, 1989

Potentiation of norepinephrine-induced contraction by primary prostaglandin receptor activation in rat aorta. European Journal of Pharmacology 243(2): 207-210, 1993

Potentiation by ouabain of barium-chloride induced contraction of smooth muscle in rabbit aorta. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 66(2): 275-283, 1970

Mediation of 5 hydroxytryptamine induced contraction of the rat urinary bladder via 5 hydroxytryptamine 2 and 5 hydroxytryptamine receptors. British Journal of Pharmacology 89(PROC SUPPL): 547P, 1986